Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.25, $0.14 better than the analyst estimate of $1.11. Revenue for the quarter came in at $594.8 million versus the consensus estimate of $597.47 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.